We talk to Jiangjiang (Chris) Zhu about his career, emerging technologies and MS-based metabolomics as a focus for his recent work.
From fundamental ion chemistry to differential mobility spectrometry: An interview with Larry Campbell from SCIEX
In this expert interview, we talk to Larry Campbell (SCIEX) about ion mobility technology focusing on SelexIONTM differential mobility spectrometry technology.
An author’s perspective: Gary Van Berkel on immediate drop on demand technology coupled with mass spectrometry
We talk to Gary J. Van Berkel about his career, emerging technologies and immediate drop on demand technology coupled with mass spectrometry as a focus for his recent work.
Challenges and future predictions for oligonucleotide analysis: an interview with Hans-Peter Vornlocher
In this interview Hans-Peter Vornlocher, managing Director of Research at LGC Axolabs (Kulmbach, Germany), reflects on his career in the oligonucleotide field discussing the benefits and challenges of using oligonucleotides, his future predictions and what emerging technologies could aid analysis in the future.
Weiping Shao discusses biomarkers, immunogenicity and the work he contributes to at Regeneron Pharmaceuticals (NY,USA).
In this interview Mohsen Rajabi (FDA) discusses the process of FDA approval, why immunogenicity assays are so important and what he believes the future may hold for immunogenicity testing.
In this interview, Shalini Prasad from the University of Texas at Dallas (TX, USA), discusses her current research in the development of a multiplex diagnostic wearable.
In this interview, Min Meng discusses the changing landscape of oligonucleotides in bioanalysis, including how the industry has changed over the last decade as well as the advantages and disadvantages of different analytical methods.
We interviewed Joe Rajarao, Client Engagement Manager at IDBS, who discusses how the use of technology, specifically software, can impact the bioanalytical field.
Jeff Duggan, Director, Bioanalytical Mass Spectrometry, Boehringer-Ingelheim Pharmaceuticals (CT, USA) started his career in pharmaceutical…